Literature DB >> 893242

Treatment with metronidazole of 48 patients with serious anaerobic infections.

H Giamarellou, K Kanellakopoulou, D Pragastis, N Tagaris, G K Daikos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 893242     DOI： 10.1093/jac/3.4.347

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

Review 1.  Clinical pharmacokinetics of metronidazole.

Authors:  E D Ralph
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

2.  Prospective, randomized, double-blind comparison of metronidazole and tobramycin with clindamycin and tobramycin in the treatment of intra-abdominal sepsis.

Authors:  J A Smith; A G Skidmore; A D Forward; A M Clarke; E Sutherland
Journal:  Ann Surg       Date:  1980-08       Impact factor: 12.969

Review 3.  Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

4.  Inactivation of metronidazole by anaerobic and aerobic bacteria.

Authors:  E D Ralph; D A Clarke
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

5.  Comparative penetration of metronidazole, clindamycin, chloramphenicol, cefoxitin, ticarcillin, and moxalactam into bone.

Authors:  J T Summersgill; L G Schupp; M J Raff
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.